Cargando…
Nonsteroidal Anti-inflammatory Drugs Dampen the Cytokine and Antibody Response to SARS-CoV-2 Infection
Identifying drugs that regulate severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and its symptoms has been a pressing area of investigation during the coronavirus disease 2019 (COVID-19) pandemic. Nonsteroidal anti-inflammatory drugs (NSAIDs), which are frequently used for the...
Autores principales: | Chen, Jennifer S., Alfajaro, Mia Madel, Chow, Ryan D., Wei, Jin, Filler, Renata B., Eisenbarth, Stephanie C., Wilen, Craig B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8092681/ https://www.ncbi.nlm.nih.gov/pubmed/33441348 http://dx.doi.org/10.1128/JVI.00014-21 |
Ejemplares similares
-
TLR3 Activation by Zika Virus Stimulates Inflammatory Cytokine Production Which Dampens the Antiviral Response Induced by RIG-I-Like Receptors
por: Plociennikowska, Agnieszka, et al.
Publicado: (2021) -
Cyclooxgenase-2 is induced by SARS-CoV-2 infection but does not affect viral entry or replication
por: Chen, Jennifer S., et al.
Publicado: (2020) -
Changes in SARS-CoV-2 Spike versus Nucleoprotein Antibody Responses Impact the Estimates of Infections in Population-Based Seroprevalence Studies
por: Fenwick, Craig, et al.
Publicado: (2021) -
Longitudinal Assessment of SARS-CoV-2-Specific T Cell Cytokine-Producing Responses for 1 Year Reveals Persistence of Multicytokine Proliferative Responses, with Greater Immunity Associated with Disease Severity
por: Lin, Jonah, et al.
Publicado: (2022) -
Coinfection with SARS-CoV-2 and Influenza A Virus Increases Disease Severity and Impairs Neutralizing Antibody and CD4(+) T Cell Responses
por: Kim, Eun-Ha, et al.
Publicado: (2022)